BUSUMITE

Serial Number 98843591
686

Registration Progress

Application Filed
Nov 8, 2024
Under Examination
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered

Trademark Image

BUSUMITE

Basic Information

Serial Number
98843591
Filing Date
November 8, 2024
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
May 20, 2025
Application
Pending
Classes
005

Rights Holder

Austin Research Labs Corp.

03
Address
500 Elk Street
Buffalo, NY 14210

Ownership History

Austin Research Labs Corp.

Original Applicant
03
Buffalo, NY

Austin Research Labs Corp.

Owner at Publication
03
Buffalo, NY

Legal Representation

Attorney
David W. Staple

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED
Apr 23, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN
Apr 23, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 23, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED
Apr 10, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2025 GNRT F NON-FINAL ACTION E-MAILED
Apr 10, 2025 CNRT R NON-FINAL ACTION WRITTEN
Apr 9, 2025 DOCK D ASSIGNED TO EXAMINER
Nov 8, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases; veterinary pharmaceutical preparations for the treatment and prevention of enteric disease; veterinary pharmaceutical preparations for the treatment and prevention of bacterial infection; veterinary pharmaceutical preparations for the treatment and prevention of diarrhea; veterinary pharmaceutical preparations for the treatment and prevention of scours in calves; clay material sold as a component ingredient of medical veterinary preparations for the treatment and prevention of bacterial infections, gastrointestinal disease, enteric disease, diarrhea, and scours in calves; medical veterinary preparations consisting of ingestible clay for the treatment and prevention of bacterial infections; medical veterinary preparations consisting of ingestible clay for the treatment and prevention of gastrointestinal disease; medical veterinary preparations consisting of ingestible clay for the treatment and prevention of enteric disease; medical veterinary preparations consisting of ingestible clay for the treatment and prevention of diarrhea; medical veterinary preparations consisting of ingestible clay for the treatment and prevention of scours in calves

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...